SGLT2 Inhibitors Reduce Heart Failure Hospitalization and Cardiovascular Death Clarity and Consistency

被引：3
|
作者：
Wiviott, Stephen D. [1 ,2 ]
Berg, David D. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, TIMI Thrombolysis Myocardial Infarct Study Grp, Boston, MA USA
[2] Brigham & Womens Hosp, TIMI Thrombolysis Myocardial Infarct Study Grp, 60 Fenwood Rd,Suite 7022, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 25期
关键词：
cardiovascular death; clinical trials; heart failure; meta-analysis; sodium-glucose cotransporter-2 inhibitors;
D O I：
10.1016/j.jacc.2023.04.035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis
    Hallow, Karen M.
    Helmlinger, Gabriel
    Greasley, Peter J.
    McMurray, John J. V.
    Boulton, David W.
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 479 - 487
  • [2] Efficacy of SGLT2 inhibitors for the reduction of cardiovascular death and heart failure hospitalization among non-diabetic heart failure patients: a meta-analysis
    Leycano, D.
    Cruz, M. G.
    Ang, E. O.
    Tiongco, R. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 184 - 184
  • [3] Hospitalization for Heart Failure and Death in New Users of SGLT2 Inhibitors in Patients With and Without Cardiovascular Disease: CVD-REAL Study
    Cavender, Matthew A.
    Norhammar, Anna
    Birkeland, Kare I.
    Jorgensen, Marit Eika
    Wilding, John P. H.
    Khunti, Kamlesh
    Fu, Alex Z.
    Bodegard, Johan
    Blak, Betina T.
    Wittbrodt, Eric T.
    Thuresson, Marcus
    Fenici, Peter
    Hammar, Niklas
    Kosiborod, Mikhail N.
    DIABETES, 2017, 66 : A99 - A100
  • [4] The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure
    Ji, Peng-juan
    Zhang, Zhuo-ya
    Yan, Qi
    Cao, Hui-li
    Zhao, Ya-jing
    Yang, Bing
    Li, Jin
    ESC HEART FAILURE, 2023, 10 (02): : 1314 - 1325
  • [5] Heart Failure: expensive SGLT2 Inhibitors
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (10) : 589 - 589
  • [6] SGLT2 Inhibitors and Heart Failure Outcomes
    Chim, Christine
    Newaz, Shahreear
    US PHARMACIST, 2020, 45 (02) : 18 - 22
  • [7] Investigating SGLT2 Inhibitors in Heart Failure
    Mann, Liz
    Smith, Andrew
    US PHARMACIST, 2023, 48 (03) : 45 - 48
  • [8] SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis
    Cardoso, Rhanderson
    Graffunder, Fabrissio P.
    Ternes, Caique M. P.
    Fernandes, Amanda
    Rocha, Ana, V
    Fernandes, Gilson
    Bhatt, Deepak L.
    ECLINICALMEDICINE, 2021, 36
  • [9] The effect of SGLT2 inhibitors treatment on left ventricular function and heart failure hospitalization in heart failure patients with reduce ejection fraction: A retrospective study
    Ramli, S. A. S.
    Ismail, A. F.
    Isa, W. Y. H. W.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 393
  • [10] A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity
    Sano, Motoaki
    JOURNAL OF CARDIOLOGY, 2018, 71 (5-6) : 471 - 476
12345